腹腔镜微创术治疗直肠癌的临床疗效及其对患者血清肿瘤标志物水平的影响被引量：4

下载PDF

导出

摘要目的探究直肠癌患者实施腹腔镜微创术治疗疗效对患者患者血清肿瘤标志物水平的影响。方法抽取80例直肠癌患者,按照入院先后顺序分为两组,各40例,对照组予以常规开腹手术,观察组予以腹腔镜微创术,对两组术后治疗效果、治疗前后血清肿瘤标志物水平进行比较。结果观察组手术时间高于对照组,肠蠕动恢复时间、住院时间短于对照组,两组有统计学意义(P<0.05),术前两组CEA、CY-FRA21-1、CA125水平比较无统计学意义(P>0.05),术后2周观察组CEA、CY-FRA21-1、CA125水平低于对照组,两组有统计学意义(P<0.05)。结论直肠癌患者予以腹腔微创术式干预,能提高临床治疗效果,降低术后血清肿瘤标志物水平,利于患者后期病情恢复。

作者郭广民

机构地区台前县人民医院外科

出处《航空航天医学杂志》 2019年第1期39-40,共2页 Journal of Aerospace medicine

关键词腹腔镜微创术直肠癌临床疗效血清肿瘤标志物

分类号 R735.37 [医药卫生—肿瘤]

引文网络
相关文献

参考文献5

1须新涛,耿辉,黄浒平,庄林渊,王东.手助腹腔镜在直肠癌治疗中的应用及对血清肿瘤标志物的影响[J].山西医药杂志,2017,46(13):1548-1550. 被引量：1
2姚宏伟,姚响芸,孙涛,修典荣.腹腔镜结直肠癌根治性切除联合同期腹腔镜或开腹肝大部切除术治疗同时性结直肠癌肝转移的疗效分析[J].中华消化外科杂志,2016,15(2):128-134. 被引量：38
3林秋疃.腹腔镜微创术治疗直肠癌的临床疗效及其对患者血清肿瘤标志物水平的影响[J].中国临床医生杂志,2018,46(7):818-821. 被引量：7
4宝音升博尔,田永静,王腾祺,孙海滨,冯海平,恩日乐图,庞健,姜宏亮,贾耀东.腹腔镜微创对直肠癌患者肛肠动力学及血清CEA,CA724水平的影响[J].现代生物医学进展,2017,17(22):4285-4288. 被引量：7
5吴亮,叶峰.腹腔镜微创术治疗结直肠癌患者的临床疗效[J].中国老年学杂志,2015,35(9):2442-2444. 被引量：8

二级参考文献46

1Chien-Chih Chen,Shung-Haur Yang,Jen-Kou Lin,Tzu-Chen Lin,Wei-Shone Chen,Jeng-Kae Jiang,Huann-Sheng Wang,Shih-Ching Chang.Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?[J]. Journal of Surgical Research . 2005 (2)
2Levy M,Visokai V,Lipska L,Topolcan O.Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma . 2008
3Siriwardena AK,Mason JM,Mullamitha S,et al.Management of colorectal cancer presenting with synchronous liver metastases[J].Nat Rev Clin Oncol,2014,11 (8):446-459.DOI:10.1038/nrclinonc.2014.90.
4Feng Q,Wei Y,Zhu D,et al.Timing of hepatectomy for resectable synchronous colorectal liver metastases:for whom simultaneous resection is more suitable-a meta-analysis[J].PLoS One,2014,9(8):e104348.DOI:10.1371/journal.pone.0104348.
5Abbott DE,Cantor SB,Hu CY,et al.Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases[J].J Am Coll Surg,2012,215(2):262-270.DOI:10.1016/j.jamcollsurg.2012.03.021.
6Thelen A,Jonas S,Benckert C,et al.Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer[J].Int J Colorectal Dis,2007,22 (10):1269-1276.DOI:10.1007/s00384-007-0286-y.
7Bonjer HJ,Deijen CL,Abis GA,et al.A randomized trial of laparoscopic versus open surgery for rectal cancer[J].N Engl J Med,2015,372 (14):1324-1332.DOI:10.1056/NEJMoa1414882.
8Yoshioka R,Hasegawa K,Mise Y,et al.Evaluation of the safety and efficacy of simultaneous resection of primary colorectal cancer and synchronous colorectal liver metastases[J].Surgery,2014,155 (3):478-485.DOI:10.1016/j.surg.2013.10.015.
9Ferretti S,Tranchart H,Buell JF,et al.Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases:Results of a Multicenter International Study[J].World J Surg,2015,39 (8):2052-2060.DOI:10.1007/s00268-015-3034-4.
10Muangkaew P,Cho JY,Han H,et al.Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases[J].J Gastrointest Surg,2015[Epub ahead of print].DOI:10.1007/s11605-015-2979-9.